MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Heterozygous mutations in the Parkin gene – two different presentations of Parkinson’s disease

    F. Barros, J. Alves, D. Reis-Carneiro, F. Moreira, A. Morgadinho (Coimbra, Portugal)

    Objective: The main objective of this work is to present two Parkinson's disease (PD) patients with heterozygous mutations in the Parkin gene (PARK – parkin)…
  • 2022 International Congress

    A Single-Centre Canadian Study of Disparities in Access to Deep Brain Stimulation for Movement Disorders

    S. Poonja, K. Yen, J. Miyasaki, A. Shetty, T. Sankar, F. Ba (Edmonton, Canada)

    Objective: To identify disparities in gender and ethnicity among deep brain stimulation (DBS) patients to reduce differences in access to care by implementing strategies to…
  • 2022 International Congress

    POOR SLEEP QUALITY AND OBESITY IN PATIENTS WITH PARKINSON’S: PRELIMINARY RESULTS OF A COHORT STUDY

    A. Ferrari Aquino, J. Garza Marichalar, D. Ortiz Zacarías, I. Estrada Bellmann, B. Chávez Luévanos (Monterrey, Mexico)

    Objective: Describe the prevalence of overweight and obesity in patients with PD who have poor quality sleep. Background: Sleep disturbances are common and often severe…
  • 2022 International Congress

    Merging global cohorts of manifesting and non-manifesting carriers of pathogenic variants in known Parkinson’s disease genes

    K. Roopnarain, E. Vollstedt,, L. Lange, S. Padmanabhan, C. Blauwendraat, A. Singleton, K. Katja, C. Klein (Luebeck, Germany)

    Objective: To create a global cohort of manifesting and non-manifesting carriers of pathogenic variants in known monogenic Parkinson's disease (PD) genes, such as LRRK2, PRKN, and PINK1, to better…
  • 2022 International Congress

    What, when and how should the information on iRBD and risk of Parkinson’s disease and related conditions be communicated?

    H. Chohan, C. Simonet, A. Gill, A. Schrag, A. Noyce, L. Pérez-Carbonell (London, United Kingdom)

    Objective: To investigate what, when and how patients with iRBD would like to receive information regarding the potential future implications of having iRBD, once diagnosis…
  • 2022 International Congress

    Improving the design of clinical trials in early-stage Parkinson’s disease by using the estimand framework

    J. Anzures-Cabrera, A. Monnet, G. Pagano (Welwyn Garden City, United Kingdom)

    Objective: To show how the estimand framework can be used to improve design of clinical trials testing treatments in early-stage Parkinson’s disease (PD). Background: The…
  • 2022 International Congress

    Validation of a wireless Home-Based Sleep Laboratory for assessment of sleep-related disorders in Parkinson’s disease

    S. Oz, A. Dagay, S. Katzav, D. Wasserman, E. Harduff, Y. Hanein, A. Mirelman (Tel Aviv, Israel)

    Objective: To examine the validity of a new wireless wearable system which measures EEG, EOG and sEMG for the assessment of sleep and sleep related…
  • 2022 International Congress

    The effect of rasagiline on nocturnal hypokinesia: the analysis of the Nocturnal Hypokinesia Questionnaire (NHQ)

    J. Sringean, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To identify the effect of rasagiline on nocturnal hypokinesia based on Nocturnal Hypokinesia Questionnaire (NHQ). Background: Nocturnal hypokinesia refers to the difficulty or the…
  • 2022 International Congress

    The role of cortical and subcortical structures in maintaining efficient network topology in Parkinson’s disease

    R. Berlot, B. Koritnik, Z. Pirtošek (Ljubljana, Slovenia)

    Objective: To assess the relative importance of cortical and subcortical nodes and their connections in maintaining efficient structural connectome topology in Parkinson's disease (PD). Background:…
  • 2022 International Congress

    Dried blood and plasma spots for the measurement of neurofilament light chain and inflammatory cytokines in patients with REM sleep behaviour disorder

    B. Huxford, C. Simonet, L. Carbonell, A. Zirra, N. Vickaryous, A. Gill, A. Schrag, R. Dobson, A. Noyce (London, United Kingdom)

    Objective: The objective of this study was to investigate the relationship between plasma and dried blood/ plasma spot measurements of inflammatory markers (IFN-ɣ, IL-1β, IL-6,…
  • « Previous Page
  • 1
  • …
  • 343
  • 344
  • 345
  • 346
  • 347
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley